Login / Signup

Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer.

Andreas IhrigPascal Marino PerntStefanie ZschäbitzJohannes HuberHans Christoph FriederichTill Johannes BugajImad Maatouk
Published in: International urology and nephrology (2023)
The study was registered in the German Clinical Trials Registry (DRKS00017727).
Keyphrases
  • prostate cancer
  • clinical trial
  • radical prostatectomy
  • bipolar disorder
  • randomized controlled trial
  • type diabetes
  • adipose tissue
  • polycystic ovary syndrome
  • metabolic syndrome
  • open label
  • bone marrow
  • phase iii